More reads
- UK biotech firm skyrockets 552% after drug lowers odds of serious COVID-19 symptoms. (Business Insider)
- Two lawmakers own large sums of stock in vaccine makers set to testify before their committee. (STAT Plus)
- Ex-Sanofi Genzyme chief David Meeker hops to a new biotech CEO post. (Endpoints)
- Sanofi forges ahead with active ingredients spin-off. (Reuters)
No hay comentarios:
Publicar un comentario